Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)
Shapiro, Charles L., Moriarty, James P., Dusetzina, Stacie, Himelstein, Andrew L., Foster, Jared C., Grubbs, Stephen S., Novotny, Paul J., Borah, Bijan J.Volume:
35
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2017.73.7437
Date:
December, 2017
File:
PDF, 591 KB
english, 2017